Synchronized Chemotherapy/Photothermal Therapy/Sonodynamic Therapy of Human Triple-Negative and Estrogen Receptor-Positive Breast Cancer Cells Using a Doxorubicin –Gold Nanoclusters–Albumin Nanobioconjugate
Novel strategies for treating triple-negative breast cancer (TNBC) are ongoing because of the lack of standard-of-care treatment. Nanoframed materials with a protein pillar are considered a valuable tool for designing multigoals of energy-absorbing/medication cargo and are a bridge to cross-conventional treatment strategies.
Source: Ultrasound in Medicine and Biology - Category: Radiology Authors: Zahra Kayani, Hossein Heli, Rezvan Dehdari Vais, Hanieh Haghighi, Mohammadreza Ajdari, Naghmeh Sattarahmady Tags: Original Contribution Source Type: research
More News: Biology | Breast Cancer | Cancer | Cancer & Oncology | Chemotherapy | Nanotechnology | Radiology | Ultrasound